Genes can stop onset of AML, study suggestsDecember 15, 2015Leukemia, Myelodysplasia, TransplantationAML
Combination offers ‘important new option’ for CLL, team saysDecember 13, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Group recommends adding rituximab to ALL therapyDecember 12, 2015Leukemia, Myelodysplasia, TransplantationALL
RATIFY trial results available after almost 10 years in the makingDecember 11, 2015Leukemia, Myelodysplasia, TransplantationAML
FDA approves rapid-infusion bendamustineDecember 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
2nd-gen BTK inhibitor may be safer, team saysDecember 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
CAR exhibits activity in resistant B-cell malignanciesDecember 9, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin Lymphoma
ALL patients over-report their 6MP compliance, researchers sayDecember 8, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Cancer drug prices vary widely from country to countryDecember 7, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
FDA approves generic imatinibDecember 6, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Team identifies potential biomarkers for AML therapyDecember 3, 2015Leukemia, Myelodysplasia, TransplantationAML
EC grants conditional approval for blinatumomabNovember 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL
Template can help guide care for cancer survivorsNovember 24, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues